Major Accomplishments
1st
Among worldwide universities for CAR-T cell patents as reported by Nature Biotechnology
722
Executed commercialization agreements, the highest number in CTT/PCI history
$114M
In annual licensing income; the most ever by Penn’s schools and faculty inventors
>$200M
Combined total of licensing income and sponsored research funding
$260M
Venture capital financing raised or received by Penn startups
4th
Most innovative university in the world as determined by Reuters